Holen Sie sich die Stockscreener-App
6.14
14.34%
0.77
Schlusskurs vom Vortag:
$5.37
Offen:
$5.52
24-Stunden-Volumen:
751.97K
Relative Volume:
2.20
Marktkapitalisierung:
$317.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.90M
KGV:
-11.58
EPS:
-0.53
Netto-Cashflow:
$-19.80M
1W Leistung:
+7.53%
1M Leistung:
+36.75%
6M Leistung:
+0.99%
1J Leistung:
+59.48%
1-Tages-Spanne:
$5.5014
$6.20
1-Wochen-Bereich:
$5.14
$6.20
52-Wochen-Spanne:
$3.19
$6.8184
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
Firmenname
Diamedica Therapeutics Inc
Sektor
Branche
Telefon
(763) 496-5454
Adresse
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Vergleichen Sie DMAC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
6.14 | 277.57M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-06-22 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-04-09 | Eingeleitet | Oppenheimer | Outperform |
| 2021-02-17 | Eingeleitet | ROTH Capital | Buy |
| 2020-10-30 | Eingeleitet | Guggenheim | Buy |
| 2020-07-08 | Eingeleitet | Maxim Group | Buy |
| 2019-04-30 | Eingeleitet | Dougherty & Company | Buy |
| 2019-03-05 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Diamedica Therapeutics Inc Aktie (DMAC) Neueste Nachrichten
DiaMedica Therapeutics Inc. stock chart pattern explainedJuly 2025 Summary & Free Technical Confirmation Trade Alerts - Newser
Volatility clustering patterns for DiaMedica Therapeutics Inc.Price Action & Weekly High Return Forecasts - Newser
Price momentum metrics for DiaMedica Therapeutics Inc. explainedMarket Risk Analysis & Risk Controlled Swing Alerts - Newser
Using AI based signals to follow DiaMedica Therapeutics Inc.Trade Risk Report & Low Drawdown Trading Techniques - Newser
Combining price and volume data for DiaMedica Therapeutics Inc.2025 Analyst Calls & Long-Term Safe Investment Plans - Newser
Full technical analysis of DiaMedica Therapeutics Inc. stock2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Ranking DiaMedica Therapeutics Inc. among high performing stocks via toolsWall Street Watch & Real-Time Chart Breakout Alerts - Newser
Is DiaMedica Therapeutics Inc. a candidate for recovery playWeekly Profit Report & Community Verified Trade Signals - Newser
DiaMedica Therapeutics Inc.’s volatility index tracking explainedJuly 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
How institutional ownership impacts DiaMedica Therapeutics Inc. stockTrade Performance Summary & Low Risk Investment Opportunities - Newser
Is DiaMedica Therapeutics Inc. stock influenced by commodity pricesTrade Performance Summary & Daily Growth Stock Investment Tips - خودرو بانک
Does DiaMedica Therapeutics Inc. have declining or rising EPS2025 Earnings Impact & Safe Investment Capital Preservation Plans - خودرو بانک
Is DiaMedica Therapeutics Inc. forming higher highs and higher lows2025 Institutional Moves & Community Consensus Stock Picks - خودرو بانک
Published on: 2025-09-05 23:26:43 - خودرو بانک
Trend analysis for DiaMedica Therapeutics Inc. this weekWeekly Profit Summary & AI Driven Stock Price Forecasts - Newser
Can DiaMedica Therapeutics Inc. sustain its profitabilityGap Up & Weekly Sector Rotation Insights - خودرو بانک
DiaMedica Therapeutics Stock (DMAC) Opinions on Insider Buying and Conference Presentations - Quiver Quantitative
Diamedica Therapeutics shares rise 3.35% premarket after announcing participation in upcoming investor conferences. - AInvest
DiaMedica Therapeutics: Investor Conferences as Catalysts for Biotech Sector Re-Rating - AInvest
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences - AInvest
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million By Investing.com - Investing.com Canada
Trill AB buys DiaMedica (DMAC) shares worth $5.96 million - Investing.com
Applying Elliott Wave Theory to DiaMedica Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Using data filters to optimize entry into DiaMedica Therapeutics Inc.2025 Retail Activity & Target Return Focused Stock Picks - Newser
Is DiaMedica Therapeutics Inc. forming a bullish divergenceJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - خودرو بانک
Should you hold or exit DiaMedica Therapeutics Inc. now2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Understanding DiaMedica Therapeutics Inc.’s price movementRate Hike & Consistent Income Trade Ideas - Newser
How cyclical is DiaMedica Therapeutics Inc.’s revenue stream2025 Institutional Moves & Daily Market Momentum Tracking - خودرو بانک
Is DiaMedica Therapeutics Inc. stock a top performer YTD2025 Historical Comparison & High Return Stock Watch Alerts - خودرو بانک
Can DiaMedica Therapeutics Inc. hit a new high this monthRisk Management & High Conviction Trade Alerts - Newser
Published on: 2025-09-03 04:58:56 - Newser
Intraday pattern recognizer results for DiaMedica Therapeutics Inc.Quarterly Profit Report & Daily Profit Focused Screening - Newser
Is DiaMedica Therapeutics Inc. stock entering bullish territoryMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Published on: 2025-09-03 08:43:38 - خودرو بانک
Applying Wyckoff theory to DiaMedica Therapeutics Inc. stockShare Buyback & Consistent Income Trade Recommendations - Newser
What to expect from DiaMedica Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Can DiaMedica Therapeutics Inc. disrupt its industryTrade Exit Summary & Entry Point Confirmation Signals - خودرو بانک
Is DiaMedica Therapeutics Inc. stock forming a cup and handleJuly 2025 Weekly Recap & Free Weekly Watchlist of Top Performers - خودرو بانک
Applying chart zones and confluence areas to DiaMedica Therapeutics Inc.2025 Risk Factors & High Win Rate Trade Alerts - Newser
Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Diamedica Therapeutics Inc-Aktie (DMAC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STAHLBERG JAN | 10% Owner |
Aug 13 '25 |
Buy |
5.91 |
293,601 |
1,734,918 |
7,058,066 |
| STAHLBERG JAN | 10% Owner |
Aug 14 '25 |
Buy |
5.99 |
70,414 |
421,921 |
7,128,480 |
| STAHLBERG JAN | 10% Owner |
Aug 20 '25 |
Buy |
5.86 |
71,107 |
416,495 |
7,207,820 |
| STAHLBERG JAN | 10% Owner |
Aug 26 '25 |
Buy |
6.00 |
59,648 |
357,888 |
7,713,693 |
| STAHLBERG JAN | 10% Owner |
Aug 22 '25 |
Buy |
5.96 |
59,788 |
356,576 |
7,315,780 |
| STAHLBERG JAN | 10% Owner |
Aug 27 '25 |
Buy |
6.00 |
50,772 |
304,632 |
7,764,465 |
| STAHLBERG JAN | 10% Owner |
Aug 21 '25 |
Buy |
5.96 |
48,172 |
287,028 |
7,255,992 |
| STAHLBERG JAN | 10% Owner |
Aug 15 '25 |
Buy |
6.00 |
8,233 |
49,398 |
7,136,713 |
| STAHLBERG JAN | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
1,542,857 |
5,400,000 |
6,764,465 |
| Von Koch Thomas | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
2,857,142 |
9,999,997 |
8,383,577 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):